Skip to main content
. 2018 Sep 11;9:2080. doi: 10.3389/fimmu.2018.02080

Figure 1.

Figure 1

Identification of an effective HBV-specific CRISPR/SaCas9 system. (A) Illustration of gRNA-targeted sequences located in the HBV genome. (B) Results of HBsAg measurement in cell-culture supernatants on the 3rd day after co-transfection with CRISPR-SaCas9 and pGL3-HBV1.2 expression vector in 293T cells. Error bars, SD; n = 3. (C) CCK-8 assay performed at the indicated time points after transfection (absorbance at 450 nm, A450). (D) Level of HBeAg in cell-culture supernatants on the 3rd day after co-transfection with CRISPR-SaCas9 and pGL3-HBV1.2 in 293T cells. Error bars, SD; n = 3.